Track ResMed Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

ResMed Inc. RME.F · Stock Open ResMed Inc. in new tab

199.40 EUR
P/E
22.30
EPS
8.94
Yield
1.14%
P/B
5.10
ROE
24.27
Beta
0.75
Loading chart...
Key Metrics
P/E22.30
EPS8.94
Book Value39.08
Price to Book5.10
Debt/Equity12.54
% Insiders0.499%
Growth
Revenue Growth0.09%
Earnings Growth0.02%
Estimates
Forward P/E30.26
Forward EPS6.59
Dividend
Dividend Yield1.14%
Annual dividends2.26 EUR
Ex-Div. DateAug. 20, 2026
Payout23.01%
5y avg Yield0.87%

DCF Valuation

Tweak assumptions to recompute fair value for ResMed Inc. (RME.F)
Currency: EUR
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

ResMed Inc. Logo ResMed Inc. Analysis (RME.F)

United States Health Care Official Website Stock

Is ResMed Inc. a good investment? ResMed Inc. (RME.F) is currently trading at 199.40 EUR.

In terms of valuation, the stock trades at a P/E ratio of 22.30. This valuation is generally in line with the broader market.

For income investors, ResMed Inc. pays a dividend yield of 1.14%. With a payout ratio of 23%, the dividend appears sustainable.

Investor FAQ

Does ResMed Inc. pay a dividend?

Yes, it pays an annual dividend of 2.26 EUR (1.14% yield).

What asset class is ResMed Inc.?

ResMed Inc. is classified as a Stock. You can compare it against 13 other assets in the "Related Symbols" list on this page.

Company Profile

ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. It also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Exchange Ticker
ASX (Australia) RMD.AX
PNK (United States) RSMDF
MEX (Mexico) RMD.MX
VIE (Austria) RMD.VI
FRA (Germany) RMD.F
BER (Germany) RME.BE
STU (Germany) RME.SG
DUS (Germany) RME.DU
FRA (Germany) RME.F
FRA (Germany) RMEA.F
MUN (Germany) RME.MU
STU (Germany) RMEA.SG
SAO (Brazil) R1MD34.SA
Trades
Dividend Yield
1.14%
5y avg 0.87%
Annual Dividends
2.26EUR
Next Ex. Div Date
Aug. 20, 2026
Payout Ratio
23.01%
Dividend History paid per year (EUR)
Historical Dividends
Year Total Dividends
2027
1.70 EUR
Aug. 12, 2027 (estimated) 0.6119
May 13, 2027 (estimated) 0.5428
Feb. 11, 2027 (estimated) 0.5428
2026
2.15 EUR
Nov. 12, 2026 (estimated) 0.5563
Aug. 20, 2026 0.5666
May 14, 2026 0.5151
Feb. 12, 2026 0.5151
2025
1.94 EUR
Nov. 13, 2025 0.5151
Aug. 14, 2025 0.5151
May 8, 2025 0.4550
Feb. 13, 2025 0.4550
2024
1.73 EUR
Nov. 7, 2024 0.4550
Aug. 15, 2024 0.4550
May 8, 2024 0.4121
Feb. 7, 2024 0.4121
2023
1.58 EUR
Nov. 8, 2023 0.4121
Aug. 16, 2023 0.4121
May 10, 2023 0.3777
Feb. 8, 2023 0.3777
2022
1.48 EUR
Nov. 9, 2022 0.3777
Aug. 17, 2022 0.3777
May 11, 2022 0.3606
Feb. 9, 2022 0.3606
2021
1.39 EUR
Nov. 9, 2021 0.3606
Aug. 18, 2021 0.3606
May 12, 2021 0.3348
Feb. 10, 2021 0.3348
2020
1.34 EUR
Nov. 10, 2020 0.3348
Aug. 19, 2020 0.3348
May 13, 2020 0.3348
Feb. 12, 2020 0.3348
2019
1.30 EUR
Nov. 6, 2019 0.3348
Aug. 14, 2019 0.3348
May 8, 2019 0.3176
Feb. 6, 2019 0.3176
2018
1.24 EUR
Nov. 7, 2018 0.3176
Aug. 15, 2018 0.3176
May 9, 2018 0.3005
Feb. 7, 2018 0.3005
2017
0.58 EUR
Nov. 8, 2017 0.3005
May 9, 2017 0.2833
2016
0.57 EUR
Nov. 8, 2016 0.2833
Aug. 16, 2016 0.2833
2015
0.74 EUR
Nov. 17, 2015 0.2576
May 19, 2015 0.2404
Feb. 10, 2015 0.2404
2014
0.91 EUR
Nov. 18, 2014 0.2404
Aug. 19, 2014 0.2404
May 16, 2014 0.2146
Feb. 17, 2014 0.2146
2013
0.72 EUR
Nov. 15, 2013 0.2146
Aug. 16, 2013 0.2146
May 17, 2013 0.1459
Feb. 14, 2013 0.1459
2012
0.29 EUR
Nov. 16, 2012 0.1459
Sept. 5, 2012 0.1459
Upcoming Dividends
Name Payment Date Status Amount
ResMed Inc. Aug 20, 2026 0.56661 EUR
ResMed Inc. May 14, 2026 0.5151 EUR
ResMed Inc. Feb 12, 2026 0.5151 EUR
ResMed Inc. Nov 13, 2025 0.5151 EUR
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion